BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home » Authors » Cormac Sheridan

Cormac Sheridan

Articles

ARTICLES

Genmab Raises DKK845.2M Via Institutional Placement

Feb. 1, 2006
By Cormac Sheridan

Amgen Plans To Build $1B Biologics Facility In Ireland

Jan. 25, 2006
By Cormac Sheridan

Amgen Plans To Build $1B Biologics Facility In Ireland

Jan. 25, 2006
By Cormac Sheridan

Finnish Institute Gets EUR3M For GMP-Grade Stem Cells

Jan. 11, 2006
By Cormac Sheridan

Symphogen Gets $25M, As Antibody Products Progress

Jan. 11, 2006
By Cormac Sheridan
Symphogen A/S raised $25 million in a Series D funding that attracted one new investor. (BioWorld International)
Read More

Symphogen Gets $25M, As Antibody Products Progress

Jan. 11, 2006
By Cormac Sheridan
Symphogen A/S raised $25 million in a Series D funding that attracted one new investor. (BioWorld International)
Read More

Finnish Institute Gets EUR3M For GMP-Grade Stem Cells

Jan. 11, 2006
By Cormac Sheridan

Santhera Spins Out Graffinity Through Management Buyout

Jan. 4, 2006
By Cormac Sheridan

Santhera Spins Out Graffinity Through Management Buyout

Jan. 4, 2006
By Cormac Sheridan

Novartis Interest Could Scuttle Crucell's Bid For Berna Biotech

Dec. 28, 2005
By Cormac Sheridan
View All Articles by Cormac Sheridan

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 9, 2026
  • Blood sample tubes after centrifuge

    Pre-disease plasma signature may help redefine lung cancer risk

    BioWorld
    Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing